ArticleAdvanced healthcare materials2026
A Novel Strategy for Achieving Immunomodulation and Osseointegration of Titanium Alloys: Boron-Doped Porous Coating Modification.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Durable performance of metallic implants depends largely on robust osseointegration and a balanced immune microenvironment at the bone-implant interface. Modulating macrophage polarization and osteoblast responses through surface topography and chemistry has emerged as an effective strategy for improving titanium alloy implants. In this study, boron-containing hierarchical porous ceramic coatings were fabricated on the low-modulus Ti-19Zr-10Nb-1Fe alloy using a one-step micro-arc oxidation process. The pore topography, surface roughness, wettability, and boron release kinetics were regulated by adjusting the applied voltage. Among the tested coatings, the M300V exhibited stronger coating adhesion and improved corrosion resistance. In vitro, the M300V coating promoted osteoblast proliferation and differentiation and induced macrophage polarization toward an M2-like phenotype. Macrophage-conditioned medium from the M300V group further enhanced osteoblast differentiation, indicating a beneficial immunomodulatory effect on osteogenesis. These responses were accompanied by increased expression of osteogenesis-related markers, including RUNX2, COL1, and OCN. In a rat femoral condyle model, the M300V coating reduced early inflammatory responses, suppressed osteoclast activity, and improved osseointegration. These findings suggest that the improved biological performance of the M300V coating may result from the combined effects of favorable boron release kinetics and hierarchical porous microstructures, providing a promising surface modification strategy for bone-interfacing titanium alloy implants.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.